US5869170A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Preparation of medical devices by solid free-form fabrication methods
Assignee: Massachusetts Institute of Technology
•
Filing: 1995-06-05
•
Granted: 1999-02-09
•
Expires: 2015-06-05
Abstract
Abstract Solid free-form techniques for making medical devices for controlled release of bioactive agent and implantation and growth of cells are described using computer aided design. Examples of SFF methods include stereo-lithography (SLA), selective laser sintering (SLS), ballistic particle manufacturing (BPM), fusion deposition modeling (FDM), and three dimensional printing (3DP). The macrostructure and porosity of the device can be manipulated by controlling printing parameters. Most importantly, these features can be designed and tailored using computer assisted design (CAD) for individual patients to optimize therapy.
Inventors
- 👤 Linda G. Cima
- 👤 Michael J. Cima
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 21:02
CPC Classifications
A; A61; A61F; A61F2/00; A61F2/02; A61F2/022; A61F2/10; A61F2/105; A61F2/28; A61K; A61K9/00; A61K9/0012; A61K9/0019; A61K9/0024; A61K9/0087; A61K9/0097; A61K9/14; A61K9/16; A61K9/1605; A61K9/1629; A61K9/1641; A61K9/1647; A61K9/1682; A61K9/1694; A61L; A61L27/00; A61L27/28; A61L27/34; A61L27/36; A61L27/38; A61L27/3804; A61L27/3808; A61L27/40; A61L27/50; A61L27/56; A61L27/60; B; B29; B29C; B29C64/00; B29C64/10; B29C64/165; B33; B33Y; B33Y10/00; B33Y70/00; B33Y70/10; B33Y80/00; A61F2/30; A61F2/30756; A61F2/3094; A61F2/0077; A61F2002/0086; A61F2002/009; A61F2002/30001; A61F2002/30003; A61F2002/30004; A61F2002/30011; A61F2002/30032; A61F2002/3006; A61F2002/30062; A61F2002/30108; A61F2002/30199; A61F2002/3028; A61F2002/30667; A61F2002/30677; A61F2/30767; A61F2002/3093; A61F2002/30932; A61F2/30942; A61F2002/30962; A61F2210/00; A61F2210/0004; A61F2230/00; A61F2230/0063; A61F2240/00; A61F2240/001; A61F2250/00; A61F2250/0014; A61F2250/0023; A61F2250/003; A61F2250/0031; A61F2250/0058; A61F2250/0067; A61F2310/00; A61F2310/00005; A61F2310/00359; B29K; B29K2995/00; B29K2995/0037; B29K2995/0063; B29K2995/0064; Y; Y10; Y10S; Y10S623/00; Y10S623/901; Y10T; Y10T428/00; Y10T428/249921; Y10T428/249953; Y10T428/249954; Y10T428/249961; Y10T428/249978; Y10T428/249986; Y10T428/249994; Y10T428/249999
Claims Analysis
Total Claims: 13
Claim 1
Independent Claim
78 words
An implantable medical device for controlled release of a bioactive agent made using a solid free-form fabrication method to form successive layers of a biocompatible material into a matrix with a defined macroscopic shape and a defined microstructure comprising porous or solid walls, and a bioactive agent selectively distributed within or between the walls of the microstructure to provide constant rate or pulsed controlled release of the bioactive agent, and/or to form a concentration gradient within the matrix.
Claim 2
Dependent Claim
78 words
An implantable medical device for controlled release of a bioactive agent made using a solid free-form fabrication method to form successive layers of a biocompatible material into a matrix with a defined macroscopic shape and a defined microstructure comprising porous or solid walls, and a bioactive agent selectively distributed within or between the walls of the microstructure to provide constant rate or pulsed controlled release of the bioactive agent, and/or to form a concentration gradient within the matrix.
Claim 3
Dependent Claim
57 words
The device of claim 1 wherein the method is ballistic particle manufacturing or fusion deposition modeling comprising applying particulate biocompatible material to a platform and bonding the particles to each other to form a layer with a defined pattern, and repeating the method to form successive layers into a matrix having a desired macroscopic shape and microstructure.
Claim 4
Dependent Claim
68 words
The device of claim 1 wherein the method is three dimensional printing, comprising preparing a dispersion of particles formed of a biocompatible material on a platform; and applying a binder or solvent for the particles to the dispersion of particles to form a layer of solidified material with a defined pattern, and repeating the method to form layers into a matrix having a desired macroscopic shape and microstructure.
Claim 5
Dependent Claim
57 words
The device of claim 1 wherein the method is selective laser sintering comprising applying particles to a platform and fusing selected areas of the particles with a laser to form a layer of solidified material with a defined pattern, and repeating the method to form sequential layers into a matrix with a desired macroscopic shape and microstructure.
Claim 6
Dependent Claim
60 words
The device of claim 1 wherein the method is stereo-lithography and the biocompatible material is photopolymerizable prepolymer or monomers comprising photopolymerizing selected areas of a bath of photopolymerizable prepolymer or monomers to form a layer of photopolymerized polymer with a defined pattern, and repeating the process to form successive layers into a matrix having a desired macroscopic shape and microstructure.
Claim 7
Dependent Claim
28 words
The device of claim 1 wherein the bioactive agent is added to particles used to form the layers of the matrix and is thereby dispersed throughout the matrix.
Claim 8
Dependent Claim
41 words
The device of claim 1 wherein the method comprises using a solvent for the bioactive agent that is not a solvent for the biocompatible material, wherein three dimensional printing is used to form discrete regions of bioactive agent within the matrix.
Claim 9
Dependent Claim
22 words
The device of claim 1 wherein the biocompatible material used in the solid free-form fabrication method is in the form of particles.
Claim 10
Dependent Claim
12 words
The device of claim 1 wherein the biocompatible material is biodegradable polymer.
Claim 11
Dependent Claim
28 words
The device of claim 1 wherein the biocompatible material is a non-degradable polymer and forms a porous matrix through which bioactive agent can diffuse out of the device.
Claim 12
Dependent Claim
20 words
The device of claim 1 wherein the bioactive agent is present in different areas of the matrix in different concentrations.
Claim 13
Dependent Claim
21 words
The device of claim 1 wherein the bioactive agent is incorporated into the matrix so as to result in pulsed release.
References Cited (Backward Citations)
US4060081A
Cited
US4787900A
Cited
US4520821A
Cited
US4485097A
Cited
US4609551A
Cited
US4620327A
Cited
US5011692A
Cited
US4927632A
Cited
US4985036A
Cited
US5171261A
Cited
US5204055A
Cited
US5059123A
Cited
US5447724A
Cited
US5197985A
Cited
US5226914A
Cited
US5460758A
Cited
DE4102259A1
Cited
US5260009A
Cited
US5338772A
Cited
US5466462A
Cited
US5370692A
Cited
US5510066A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2002-02-08 | 2002-08-10 | 2003-02-09 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2006-02-08 | 2006-08-10 | 2007-02-09 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2010-02-08 | 2010-08-10 | 2011-02-09 | $7700.00 | Window Closed / Lapsed |